Squarepoint’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.16M | Buy |
102,642
+44,986
| +78% | +$1.82M | ﹤0.01% | 854 |
|
2025
Q1 | $2.96M | Buy |
57,656
+51,652
| +860% | +$2.65M | ﹤0.01% | 977 |
|
2024
Q4 | $332K | Sell |
6,004
-51,329
| -90% | -$2.84M | ﹤0.01% | 2138 |
|
2024
Q3 | $1.89M | Buy |
+57,333
| New | +$1.89M | ﹤0.01% | 1153 |
|
2024
Q2 | – | Sell |
-33,867
| Closed | -$1.23M | – | 2966 |
|
2024
Q1 | $1.23M | Buy |
+33,867
| New | +$1.23M | ﹤0.01% | 1252 |
|
2023
Q4 | – | Sell |
-19,344
| Closed | -$344K | – | 2959 |
|
2023
Q3 | $344K | Buy |
19,344
+9,303
| +93% | +$165K | ﹤0.01% | 1847 |
|
2023
Q2 | $181K | Sell |
10,041
-3,896
| -28% | -$70.4K | ﹤0.01% | 2106 |
|
2023
Q1 | $175K | Buy |
+13,937
| New | +$175K | ﹤0.01% | 1910 |
|